. In contrast, glial proliferation in the optic nerve was unaffected, indicating that PDGF is not released from axons. When PDGF was expressed directly in the optic nerve under the control of an astrocyte-specific promoter (GFAP--PDGF-A), oligodendrocyte progenitors hyperproliferated, resulting in a hypertrophic optic nerve. We conclude that PDGF is constitutively secreted from neuronal cell bodies in vivo, but not from axons in white-matter tracts.
it is not known whether they target PDGF to their axons or, if so, whether they can release PDGF into the nerve. Resident optic nerve astrocytes also synthesise PDGF-A [1] . It is difficult to establish whether RGCs or optic nerve astrocytes normally deliver PDGF-AA (the secreted dimer of PDGF-A) to the optic nerve because growth factors typically act at low concentrations and are difficult to trace once they are released into the extracellular milieu. We bypassed this difficulty by using a physiological measure of PDGF activity in vivo. We overexpressed PDGF-A either in neurons or astrocytes in transgenic mice and studied the proliferative response of PDGF-responsive glial cells. We monitored oligodendrocyte progenitors (OLPs) in the optic nerve and astrocytes in the retina; both these cell types express PDGFRα [1] , allowing us to identify and count them by in situ hybridisation with a PDGFRα probe.
The pre-existing NSE-hPDGF-A transgenic mice [4, 6] express human PDGF-A under the control of the mouse NSE promoter (Figure 1 ). In case human PDGF-AA might be targeted or secreted abnormally in mouse cells, we generated a new line that overexpresses mouse PDGF-A (NSE-mPDGF-A). We also generated control mice expressing human PDGF-A in astrocytes under the 
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mouse GFAP promoter (GFAP-hPDGF-A; Figure 1 ). In NSE-hPDGF-A mice, hPDGF-A was expressed by RGCs and cells in the inner nuclear layer of the retina (Figure 2b and [4] ), and in GFAP-hPDGF-A mice the transgene was expressed in retinal astrocytes (Figure 2c ). The effects of the transgene in the retina were analysed by visualising retinal astrocytes by in situ hybridisation with a probe against PDGFRα. In all transgenic mouse strains, there was marked hyperplasia of retinal astrocytes (Figure 2f-h) . In NSE-hPDGF-A and NSE-mPDGF-A mice, this reflected PDGF-AA release from RGC cell bodies, resulting in a paracrine neuron-astrocyte interaction in the retina. This confirms that the transgene is secreted in an active form by RGCs. In GFAP-hPDGF-A mice, a PDGF-AA-PDGFRα autocrine loop is created in retinal astrocytes themselves.
We confirmed by in situ hybridisation that in NSE-hPDGF-A P1 mice there was no production of transgenic PDGF-A mRNA in the optic nerve (Figure 3b ). This was as expected, as there are no resident neurons in the nerve. In contrast, we found strong transgene expression by optic nerve astrocytes in GFAP-hPDGF-A mice (Figure 3c ), again as expected. At P1, proliferating OLPs are just starting to populate the optic nerve by inward migration from the brain through the optic chiasm [1] . Therefore, we analysed OLP numbers in the optic nerve at P7, by which time the nerve is normally full of OLPs [1] . We visualised OLPs in the optic nerve by in situ hybridisation for PDGFRα. No increase of OLP numbers could be detected in the optic nerves of either NSE-hPDGF-A or NSE-mPDGF-A mice (Figure 3f ,h), suggesting that no extra PDGF is released into the optic nerves of these mice. In contrast, we found a dramatic increase of PDGFRα + OLP numbers in the optic nerves of GFAP-hPDGF-A mice compared with wild-type littermates ( Figure 3g ). Counting OLPs in optic nerve cross sections revealed no differences between wild-type (average 25 ± 2), NSE-hPDGF-A (24 ± 2) or NSE-mPDGF-A (24 ± 3) mice but about a threefold increase in GFAP-hPDGF-A mice (77 ± 8; see Materials and methods). This was accompanied by a marked increase in the diameter of the optic nerve ( Figure 3g ). Closer inspection by electron microscopy revealed that this size increase resulted from an increase of oligodendrocyte lineage cells, with no increase in the number of optic nerve astrocytes (W. Blakemore, personal communication). This was as expected because optic nerve astrocytes do not express PDGFRα.
It was possible that a slight increase in OLP numbers might not have been detected against the normal background of OLPs in wild-type nerves. We therefore investigated the effect of the NSE-hPDGF-A transgene in PDGF-A null mice [7] , which have almost no OLPs in their optic nerves (Figure 4b ), as a result of which they remain practically unmyelinated [5] . We crossed the NSE-hPDGF-A transgene into the PDGF-A null background but this did not result in any rescue of OLP numbers in the optic nerve whatsoever (Figure 4d) . As a control, we analysed OLPs in the spinal cord, which, in contrast to the optic nerve, contains neuronal cell bodies as well as axon tracts. As previously reported, there were increased numbers of progenitor cells in spinal cords of NSE-hPDGF-A mice compared with wild-type mice ( [6] and Figure 4e,g ). In PDGF-A null mice, there were very few OLPs (< 5% of normal; [5, 6] and Figure 4f ). On top of Our results indicate that PDGF-AA is released from neuronal cell bodies but not from axons. This is consistent with the fact that cultured endothelial cells secrete PDGF-BB almost exclusively from the basal surface [8] , as the basolateral domain of endothelial cells is thought to be equivalent to the somatodendritic region of neurons. It therefore appears that, in the optic nerve, OLP proliferation is entirely dependent on astrocyte-derived PDGF-AA. This conclusion is also supported by the fact that intraocular injection of colchicine, which blocks fast axonal transport, does not affect OLP proliferation in the optic nerve [9] . On the other hand, blocking electrical activity in RGC axons inhibits OLP proliferation in the optic nerve [10] .
Taking that result together with the data described here it seems likely that, as suggested by Barres and Raff [11] , an activity-dependent signal from RGC axons stimulates the secretion of mitogens, including PDGF-AA, from astrocytes in the optic nerve.
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Figure 3
Transgenic PDGF-A increases OLP numbers in the optic nerve only in GFAP-PDGF-A but not in NSE-PDGF-A mice. Cross-sections through the optic nerves of (a,e) wild-type mice, or mice expressing the Wild type
NSE-hPDGF-A GFAP-hPDGF-A NSE-mPDGF-A
Figure 4
In PDGF-A null mice, transgenic PDGF-A expressed in neurons can restore OLP numbers in the spinal cord (which contains both axons and neuronal cell bodies) but not in the optic nerve (which contains axons but no cell bodies). (a-d) In situ hybridisation with a probe against PDGFRα to visualise OLPs in longitudinal sections of P5 optic nerves. The entire length of the optic nerve was reconstructed from several adjacent sections. In (a) wild-type mice, the optic nerve was populated by PDGFRα + OLPs, whereas they were absent from the optic nerve of There is immunohistochemical evidence that PDGF is present in growth cones of neurons in the developing CNS [12] . This implies that PDGF is transported in an anterograde direction along axons. We were previously unable to detect PDGF-A immunoreactivity in RGC axons in the optic nerve although very weak immunoreactivity was present in RGC cell bodies and proximal axons in the retina [1] . Our failure to detect PDGF in optic nerve axons might have been a technical problem resulting from low concentrations of PDGF, or it might have been due to epitope masking by protein-protein interactions. In any case, our present data demonstrate that, even if PDGF is transported through the optic nerve, it is not released from axons during transit. Other diffusible polypeptides, for example brain-derived neurotrophic factor (BDNF), are believed to be transported in an anterograde direction along axons and to be secreted from nerve terminals [13, 14] . It will be interesting and important to determine how transport occurs and whether it is generally true that such factors are prevented from being released into axon tracts. This would have major implications for neuron-glial interactions in white-matter tracts.
Materials and methods
Transgenic mice
Production of NSE-hPDGF-A mice has been described [4] . NSE-mPDGF-A and GFAP-hPDGF-A mice were produced according to standard techniques [15] . The NSE-mPDGF-A transgene was constructed by replacing hPDGF with mPDGF [16] in the NSE-hPDGF-A vector. The GFAP-hPDGF-A transgene contains the GFAP promoter [17] and a human PDGF-A cDNA engineered to encode the 'short' alternative-splice isoform [18] . The hPDGF-A cDNA was taken from the same plasmid that was used for production of the NSE-hPDGF-A mice [4] . Five GFAP-PDGF-A founder mice were produced, of which two died before reaching sexual maturity. The remaining three founders were used to establish lines. The observable phenotypes were indistinguishable in all three lines (data not shown) but the results described in this paper are derived from one line only.
With the NSE-mPDGF-A transgene, four founder mice were created. One of them expressed the transgene and was used to establish a line.
In situ hybridisation and quantification of OLP numbers
Cryosections were processed for in situ hybridisation with digoxigeninlabelled probes (human PDGF-A and mouse PDGFRα) as described previously [5] . OLPs were counted in five cross-sections of optic nerves from three different mice of each genotype and expressed as mean and standard deviation for each genotype.
